# Calcium Bone Density Meta-analysis: What the Evidence Says
Canonical: https://www.migaku.app/guides/calcium-bone-density-meta-analysis-evidence-review
Category: evidence-review
Summary: Calcium Bone Density Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are syst
Last reviewed: 2026-05-26
Reviewed by: Migaku Evidence Review
# Calcium Bone Density Meta-analysis: What the Evidence Says

## Quick Answer

Calcium Bone Density Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

## Key Takeaways

- This page is generated only from sources stored in the Migaku evidence knowledge base.
- Current evidence mix: 2 systematic review.
- Claims should be interpreted with the source type, study design, population, and publication date in mind.
- This article is educational and does not replace care from a qualified clinician.

## Evidence Map

| Source | Evidence type | Level | Date | Identifier |
| --- | --- | ---: | --- | --- |
| Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials | systematic review | 1 | 2026-05-01 | 10.1210/clinem/dgag005 |
| Association between dietary fiber intake and bone mineral density: a systematic review and meta-analysis of observational studies | systematic review | 1 | 2026-02-25 | 10.1007/s00394-025-03866-9 |

## What The Sources Report

- FHA is a state of estrogen deficiency leading to detrimental skeletal effects, including insufficient peak bone mass accrual if onset is in adolescent/early adult life, low BMD, impaired bone microarchitecture, and resultant increased fracture risk. [Efthymiadis Agathoklis (2026); evidence level 1]
- Indeed, fracture risk is 2-7 times higher than in age and sex-matched healthy women. [Efthymiadis Agathoklis (2026); evidence level 1]
- Osteoporosis is a prevalent chronic disease characterized by systemic deterioration in bone mass and microstructures, leading to an increased risk of fractures. [Pang Yuqi (2026); evidence level 1]
- As global population ages, the impairment of physical function, comorbidity, and mortality associated with osteoporosis is expected to rise, thereby bringing a huge medical and social burden. [Pang Yuqi (2026); evidence level 1]

## How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

## Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For calcium bone density meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

## Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

## References

- Efthymiadis Agathoklis (2026). Pharmacological interventions to improve bone density in functional hypothalamic amenorrhea: a systematic review and network meta-analysis of randomized clinical trials. DOI: 10.1210/clinem/dgag005. PMCID: PMC13099214. PMID: 41505334. License: https://creativecommons.org/licenses/by-nc-nd/4.0/ https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open.... https://pmc.ncbi.nlm.nih.gov/articles/PMC13099214/
- Pang Yuqi (2026). Association between dietary fiber intake and bone mineral density: a systematic review and meta-analysis of observational studies. DOI: 10.1007/s00394-025-03866-9. PMCID: PMC12935702. PMID: 41739242. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12935702/

## Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.